Community Acquired Pneumonia (cap) Clinical Trials
2 recruiting trials for Community Acquired Pneumonia (cap). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Community Acquired Pneumonia (cap) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Societa Italiana di Pneumologia (1), University Hospital, Caen (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Antibiotic prescribing according to guidelines (other, 1 trial).
Track Community Acquired Pneumonia (cap) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)
This multicentric, prospective study aims at: evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for...
Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
Antimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibiotic use-especially...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Community Acquired Pneumonia (cap), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Community Acquired Pneumonia (cap), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Community Acquired Pneumonia (cap), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.